The complaint, spanning 54 pages, mirrors a range of pandemic-era anti-vaccine misinformation and unsupported claims. Central to the lawsuit is the critique of Pfizer’s use of relative risk reduction in calculating the vaccine’s efficacy. Paxton argues that Pfizer should have employed absolute risk reduction, which would have depicted a significantly lower effectiveness rate.
This argument, however, has been widely discredited by health experts. They emphasize the importance of relative risk reduction in evaluating vaccine effectiveness. According to Pfizer’s trial data, the vaccine showed a 95% effectiveness based on relative risk reduction. In contrast, using absolute risk reduction, the effectiveness would be just 0.85%.
Despite these claims, Pfizer maintains that its representations of the vaccine were accurate and science-based. The company has expressed its intention to contest the lawsuit in court, underscoring the vaccine’s proven benefits and safety. The lawsuit seeks $10 million in reparations from Pfizer.
Read Full Story
Ars Technica Rating
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
